866-997-4948(US-Canada Toll Free)

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

Published By :

GlobalData

Published Date : Dec 2014

Category :

Clinical Trials

No. of Pages : 60 Pages


GlobalData's clinical trial report, Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides data on the Onchocerciasis (River Blindness) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Onchocerciasis (River Blindness). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Onchocerciasis (River Blindness). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Onchocerciasis (River Blindness) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Onchocerciasis (River Blindness) 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Onchocerciasis (River Blindness) Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Johnson & Johnson 30
Clinical Trial Overview of Johnson & Johnson 30
Clinical Trial Overview of Top Institutes / Government 31
Liverpool School of Tropical Medicine 31
Clinical Trial Overview of Liverpool School of Tropical Medicine 31
Washington University School of Medicine 32
Clinical Trial Overview of Washington University School of Medicine 32
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases 33
Clinical Trial Overview of UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases 33
University of California, San Francisco 34
Clinical Trial Overview of University of California, San Francisco 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
University Hospitals Case Medical Center 36
Clinical Trial Overview of University Hospitals Case Medical Center 36
European Commission 37
Clinical Trial Overview of European Commission 37
Case Western Reserve University 38
Clinical Trial Overview of Case Western Reserve University 38
Centers for Disease Control and Prevention 39
Clinical Trial Overview of Centers for Disease Control and Prevention 39
University of Medicine and Dentistry New Jersey (Inactive) 40
Clinical Trial Overview of University of Medicine and Dentistry New Jersey (Inactive) 40
Five Key Clinical Profiles 41

Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Table


Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Onchocerciasis (River Blindness) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Onchocerciasis (River Blindness) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Onchocerciasis (River Blindness) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Onchocerciasis (River Blindness) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 29
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 30
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Liverpool School of Tropical Medicine, 2014* 31
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 32
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2014* 33
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 34
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Case Medical Center, 2014* 36
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by European Commission, 2014* 37
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2014* 38
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014* 39
Onchocerciasis (River Blindness) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey (Inactive), 2014* 40

List of Chart


Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Onchocerciasis (River Blindness) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Onchocerciasis (River Blindness) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Onchocerciasis (River Blindness) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Onchocerciasis (River Blindness) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Onchocerciasis (River Blindness) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 59

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *